WallStreetZenWallStreetZen

NASDAQ: MEDS
Trxade Health Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their MEDS stock forecasts and price targets.

Forecast return on equity

Is MEDS forecast to generate an efficient return?

Forecast return on assets

Is MEDS forecast to generate an efficient return on assets?

MEDS revenue forecast

What is MEDS's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$9.3M+12.42%

MEDS vs Pharmaceutical Retailer Stocks

TickerPricePrice TargetUp/downsideConsensus
MEDS$6.45N/AN/A
LFLY$2.12$6.00+183.02%Strong Buy
CJJD$2.86N/AN/A
SSY$0.65N/AN/A
BIMI$1.21N/AN/A

Trxade Health Stock Forecast FAQ

What is MEDS's revenue growth forecast for 2024-2024?

(NASDAQ: MEDS) Trxade Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Trxade Health's revenue in 2024 is $8,272,214.

In 2024, MEDS is forecast to generate $13,079,036 in revenue, with the lowest revenue forecast at $13,079,036 and the highest revenue forecast at $13,079,036.

If you're new to stock investing, here's how to buy Trxade Health stock.

What is MEDS's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: MEDS) forecast ROA is N/A, which is lower than the forecast US Pharmaceutical Retailers industry average of 4.79%.

What is MEDS's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: MEDS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.